Questions discussed in this category

Is there anything to differentiate the two agents? CNS penetration reportedly with adagrasib, FDA accelerated approval has been given with sotorasib.&...

Specifically, for cT2N0M0 small cell bladder cancer without response to neoadjuvant cisplatin and etoposide on imaging, would you proceed with cystect...

High enough risk to justify anthracycline+taxane chemotherapy followed by ovarian suppression + aromatase inhibition.

Papers discussed in this category

N. Engl. J. Med., 2019 Sep 28

Clinical genitourinary cancer, 2017-06

The Journal of urology, 2014-02

European urology focus, 2018-12

Int J Radiat Oncol Biol Phys, 2015 Jul 15

Clin Genitourin Cancer, 2019 Mar 28

Int J Radiat Oncol Biol Phys, 2021 Feb 06

Am Soc Clin Oncol Educ Book,

Ann Oncol, 2013 Mar 01

N Engl J Med, 2022 Jun 03

Oncology, 2020 May 28